Hancock Whitney’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $557K | Sell |
7,594
-9,964
| -57% | -$731K | 0.01% | 540 |
|
2025
Q1 | $2.01M | Sell |
17,558
-663
| -4% | -$75.7K | 0.07% | 207 |
|
2024
Q4 | $918K | Sell |
18,221
-4,733
| -21% | -$238K | 0.03% | 326 |
|
2024
Q3 | $1.06M | Buy |
22,954
+270
| +1% | +$12.5K | 0.03% | 305 |
|
2024
Q2 | $737K | Sell |
22,684
-4,813
| -18% | -$156K | 0.03% | 348 |
|
2024
Q1 | $693K | Buy |
27,497
+15,567
| +130% | +$392K | 0.02% | 367 |
|
2023
Q4 | $387K | Sell |
11,930
-18
| -0.2% | -$585 | 0.01% | 490 |
|
2023
Q3 | $326K | Sell |
11,948
-432
| -3% | -$11.8K | 0.01% | 514 |
|
2023
Q2 | $275K | Sell |
12,380
-5,092
| -29% | -$113K | 0.01% | 550 |
|
2023
Q1 | $378K | Sell |
17,472
-2,564
| -13% | -$55.5K | 0.02% | 487 |
|
2022
Q4 | $407K | Sell |
20,036
-75
| -0.4% | -$1.52K | 0.02% | 470 |
|
2022
Q3 | $516K | Sell |
20,111
-467
| -2% | -$12K | 0.02% | 410 |
|
2022
Q2 | $489K | Sell |
20,578
-789
| -4% | -$18.7K | 0.02% | 424 |
|
2022
Q1 | $481K | Sell |
21,367
-4,366
| -17% | -$98.3K | 0.02% | 477 |
|
2021
Q4 | $510K | Sell |
25,733
-203
| -0.8% | -$4.02K | 0.02% | 480 |
|
2021
Q3 | $510K | Sell |
25,936
-93
| -0.4% | -$1.83K | 0.02% | 471 |
|
2021
Q2 | $573K | Sell |
26,029
-7,755
| -23% | -$171K | 0.02% | 521 |
|
2021
Q1 | $803K | Sell |
33,784
-484
| -1% | -$11.5K | 0.03% | 449 |
|
2020
Q4 | $897K | Sell |
34,268
-197
| -0.6% | -$5.16K | 0.03% | 403 |
|
2020
Q3 | $599K | Sell |
34,465
-171
| -0.5% | -$2.97K | 0.02% | 472 |
|
2020
Q2 | $583K | Sell |
34,636
-4,241
| -11% | -$71.4K | 0.02% | 482 |
|
2020
Q1 | $462K | Buy |
38,877
+11,117
| +40% | +$132K | 0.02% | 526 |
|
2019
Q4 | $336K | Sell |
27,760
-14,760
| -35% | -$179K | 0.01% | 651 |
|
2019
Q3 | $601K | Sell |
42,520
-5,902
| -12% | -$83.4K | 0.02% | 543 |
|
2019
Q2 | $540K | Buy |
+48,422
| New | +$540K | 0.02% | 603 |
|